ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.915,40
-0,93%
Dow Jones
42.614,27
-0,88%
Euro vs US Dollar
1,03897
-0,37%
Bitcoin
91.922,15
-1,71%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Amarin Corp PLC (AMRN) Börsenkurse

Amarin Corp PLC

Amarin Corp PLC (AMRN)

NASDAQ
0,44035
-0,00765
( -1,71% )
Aktualisiert: 17:41:23
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,44035
Gebot
0,4403
Fragen
0,4404
Volumen
1.932.810
0,431 Tagesbereich 0,4464
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
181,133M
Handelsende
0,448
Handelsbeginn
0,44
Letzte Trade
50
@
0.44035
Letzter Handelszeitpunkt
17:42:48
Finanzvolumen
US$ 847.790
VWAP
0,438631
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
411.338.131
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
306,91M
Nettogewinn
-59,11M

Über Amarin Corp PLC

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa. Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.amarincorp.com
Hauptsitz
London, Gbr
Gegründet
-
Amarin Corp PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRN. The last closing price for Amarin was US$0,45. Over the last year, Amarin shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Amarin currently has 411.338.131 shares in issue. The market capitalisation of Amarin is US$184,28 million.

AMRN Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

18 Dezember 2024
Edgar (US Regulatory)

Amarin Receives National Reimbursement for VAZKEPA® in Italy

-- Italian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Cardiovascular Risk in Eligible High-Risk Patients1 -- -- Italy is the Third EU5 Market to...

16 Dezember 2024
GlobeNewswire Inc.

Amarin Appoints Peter Fishman Chief Financial Officer

DUBLIN and BRIDGEWATER, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Peter Fishman has been appointed as Chief Financial Officer for the...

13 Dezember 2024
GlobeNewswire Inc.

Form 8-K - Current report

22 November 2024
Edgar (US Regulatory)

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual

DUBLIN and BRIDGEWATER, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that investigators will present an additional subgroup analysis from the...

11 November 2024
GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities

31 Oktober 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

30 Oktober 2024
Edgar (US Regulatory)

Form 8-K - Current report

30 Oktober 2024
Edgar (US Regulatory)

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

 -- Strong Cash Position of $306 Million; 9th Consecutive Quarter of Positive or Neutral Cash Balance Total Net Revenue of $42 Million Represents Continued Source of Cash from the U.S., RoW...

30 Oktober 2024
GlobeNewswire Inc.

Amarin Announces Two Upcoming Investor Events

-- Company to Report Third Quarter 2024 Financial Results Wednesday, October 30 –- -- Amarin to Hold Virtual Analyst & Investor Day Thursday, November 14 -- DUBLIN and BRIDGEWATER, N.J...

01 Oktober 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

AMRN - Frequently Asked Questions (FAQ)

What is the current Amarin share price?
The current share price of Amarin is US$ 0,44035
How many Amarin shares are in issue?
Amarin has 411.338.131 shares in issue
What is the market cap of Amarin?
The market capitalisation of Amarin is USD 184,28M
What is the 1 year trading range for Amarin share price?
Amarin has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Amarin?
Amarin reports financial results in USD
What is the latest annual turnover for Amarin?
The latest annual turnover of Amarin is USD 306,91M
What is the latest annual profit for Amarin?
The latest annual profit of Amarin is USD -59,11M
What is the registered address of Amarin?
The registered address for Amarin is ONE NEW CHANGE, LONDON, EC4M 9AF
What is the Amarin website address?
The website address for Amarin is www.amarincorp.com
Which industry sector does Amarin operate in?
Amarin operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NXUNXU Inc
US$ 1,22
(401,23%)
328,87M
WATTEnergous Corporation
US$ 1,605
(290,32%)
155,23M
INTZIntrusion Inc
US$ 5,3797
(149,06%)
104,75M
CYNCYNGN Inc
US$ 1,3101
(108,65%)
50,98M
VINCVincerx Inc
US$ 0,3643
(87,78%)
278,37M
ABPAbpro Holdings Inc
US$ 2,21
(-50,78%)
1,01M
TRAWTraws Pharma Inc
US$ 8,01
(-40,31%)
781,07k
LITMSnow Lake Resources Ltd
US$ 1,1617
(-27,39%)
40,12M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66,40
(-24,94%)
7,25k
LICNLichen China Limited
US$ 0,1801
(-22,40%)
26,44M
NXUNXU Inc
US$ 1,22
(401,23%)
332,24M
VINCVincerx Inc
US$ 0,3643
(87,78%)
278,7M
XTIAXTI Aerospace Inc
US$ 0,04
(1,27%)
156,17M
WATTEnergous Corporation
US$ 1,605
(290,32%)
155,97M
INTZIntrusion Inc
US$ 5,3797
(149,06%)
106,24M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
AMRN
Amarin
BIT
NSCIT9091868
ING Groep
BIT
NSCIT0535905
P&A Public Lighting
LSE
82KW
Caixa Pen Prf
BIT
NSCIT5368484
Lottomatica
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten